Tag: Covid-19 treatment
19 SARS-CoV-2 mutations in India can evade antibodies, 1 causes reinfection — CSIR study
Study suggests that N501Y, the ‘highly infectious’ Covid mutation found in UK, is present in Australia, South Africa, USA, Denmark & Brazil, and advises screening travellers from here.
CSIR plans clinical trials of antiviral Molnupiravir that is said to block Covid transmission
A recent study at Georgia State University in US found that Molnupiravir can completely suppress SARS-CoV-2 transmission in ferrets within 24 hours.
Monitor efficacy of Itolizumab, not just safety, in Covid trials — expert panel tells Biocon
Govt's expert panel, that advises the apex drug regulator, has asked Biocon to submit a revised proposal for phase 4 trials of Itolizumab, which already has emergency use approval.
Delhi gets tough with enforcing Covid home isolation, over 70 FIRs registered so far
Several people are also being moved to Covid-19 care or quarantine centres and issued strict warnings to prevent them from turning ‘super-spreaders’.
Former Assam CM Tarun Gogoi’s condition extremely critical, say doctors
Gogoi, who was undergoing treatment for post Covid complications, suffered a multi-organ failure, and was on dialysis Sunday.
Covid patients shed viral RNA for upto 83 days but are infectious for about 9 — Lancet report
Researchers from UK and Italy wrote in The Lancet Microbe journal it is important to quickly isolate patients as they are most infectious in the first week of their illness.
Doctors work 14-hr shift, handle double workload as Delhi hospitals battle staff crunch
From Delhi govt’s GTB Hospital & Rajiv Gandhi Super Specialty Hospital, to central govt’s Lady Hardinge, a similar resource crunch appears to be at play everywhere.
Delhi’s 3rd Covid wave brings back shortage of ICU beds, hospitals struggle to admit patients
As Delhi's active Covid cases touched 42,000 Tuesday, authorities are working to bolster the city's hospital bed availability by 80% in coming days.
‘Long Covid’ causing organ impairments in 70% of low-risk patients, says UK study
The study found that heart and lung impairment were just as prevalent in low-risk individuals with long Covid as the older counterparts.
Inhaling immune protein interferon beta improves recovery of Covid patients — Lancet study
The peer-reviewed study provides first evidence that inhaled interferon beta-1a, a naturally-occurring protein, reduces clinical consequences in Covid-19 patients.